Skip to content
Med Pharma News

Med Pharma News

Your Daily Dose of Pharma News

  • About Med Pharma News
  • Contact Us
  • News
  • Privacy Policy
  • Terms and Conditions
  • Home
  • Exparel

Tag: Exparel

Viatris Pacira acquisition infographic with $1.65 billion deal value and $36.50 per share price
  • Pharmaceuticals

Viatris Pacira Acquisition Closes: $1.65B Buys Exparel and a Non-Opioid Pain Franchise

Megan Wood6 hours ago6 hours ago010 mins

Viatris has closed its $1.65 billion, $36.50-a-share purchase of Pacira BioSciences, adding non-opioid pain drugs Exparel and Zilretta. Deal numbers, strategy and risks explained.

Read More

Categories

  • Healthcare IT (26)
  • Industry Insights (362)
  • Lifestyle and Wellness (24)
  • Medical Devices (45)
  • Pharmaceuticals (111)
  • Uncategorized (1)

Recent Posts

  • Novartis Sales Growth Guidance: 5% a Year to 2031 as Kesimpta Peak Rises to $8B
  • FloLipid Withdrawal: FDA Moves to Pull the First US Liquid Statin Over Missing Annual Reports
  • Viatris Pacira Acquisition Closes: $1.65B Buys Exparel and a Non-Opioid Pain Franchise
  • NAC Supplement FDA Rule: Agency Moves to Make N-Acetylcysteine a Lawful Supplement After 6-Year Fight
  • UnitedHealthcare Pharmacist Program: Independent Pharmacies Get Paid for Medicaid Care in 7 States
Digital Newspaper - Multipurpose News WordPress Theme 2026. Powered By BlazeThemes.